Early Crohn disease: a proposed definition for use in disease-modification trials

被引：106
|
作者：
Peyrin-Biroulet, Laurent [1 ]
Loftus, Edward V., Jr. [1 ]
Colombel, Jean-Frederic [2 ]
Sandborn, William J. [1 ]
机构：
[1] Mayo Clin, Div Gastroenterol & Hepatol, Inflammatory Bowel Dis Clin, Rochester, MN 55905 USA
[2] CHU Lille, Hop Claude Huriez, F-59037 Lille, France
来源：
GUT | 2010年 / 59卷 / 02期
关键词：
EARLY RHEUMATOID-ARTHRITIS; INFLAMMATORY-BOWEL-DISEASE; POPULATION-BASED COHORT; C-REACTIVE PROTEIN; NATURAL-HISTORY; COMPUTED-TOMOGRAPHY; CYTOKINE PRODUCTION; RADIATION-EXPOSURE; CLINICAL-TRIALS; OLMSTED COUNTY;
D O I：
10.1136/gut.2009.187120
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：141 / 147
页数：7
相关论文
共 50 条
  • [1] Development of the Paris Definition of Early Crohn's Disease for Disease-Modification Trials: Results of an International Expert Opinion Process
    Peyrin-Biroulet, Laurent
    Billioud, Vincent
    D'Haens, Geert
    Panaccione, Remo
    Feagan, Brian
    Panes, Julian
    Danese, Silvio
    Schreiber, Stefan
    Ogata, Haruhiko
    Hibi, Toshifumi
    Higgins, Peter D. R.
    Beaugerie, Laurent
    Chowers, Yehuda
    Louis, Edouard
    Steinwurz, Flavio
    Reinisch, Walter
    Rutgeerts, Paul
    Colombel, Jean-Frederic
    Travis, Simon
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (12): : 1770 - 1776
  • [2] Biological outcomes in disease-modification trials
    Galasko, D
    NEUROBIOLOGY OF AGING, 2004, 25 : S11 - S11
  • [3] Applications of neuroimaging to disease-modification trials in Alzheimer's disease
    Fleisher, Adam S.
    Donohue, Michael
    Chen, Kewei
    Brewer, James B.
    Aisen, Paul S.
    BEHAVIOURAL NEUROLOGY, 2009, 21 (1-2) : 129 - 136
  • [4] Prodromal Parkinson's disease: hype or hope for disease-modification trials?
    Mahlknecht, Philipp
    Marini, Kathrin
    Werkmann, Mario
    Poewe, Werner
    Seppi, Klaus
    TRANSLATIONAL NEURODEGENERATION, 2022, 11 (01)
  • [5] Early intervention in Crohn's disease: towards disease modification trials
    Danese, Silvio
    Fiorino, Gionata
    Peyrin-Biroulet, Laurent
    GUT, 2017, 66 (12) : 2179 - 2187
  • [6] Prodromal Parkinson's disease: hype or hope for disease-modification trials?
    Philipp Mahlknecht
    Kathrin Marini
    Mario Werkmann
    Werner Poewe
    Klaus Seppi
    Translational Neurodegeneration, 11
  • [7] "Disease-modification" trials in Parkinson disease: Target populations, endpoints and study design
    Rascol, Olivier
    NEUROLOGY, 2009, 72 : S51 - S58
  • [8] Preparing for Disease-Modification Trials in Degenerative Cerebellar Ataxias: Which Endpoints to Choose?
    Maas, Roderick P. P. W. M.
    MOVEMENT DISORDERS, 2023, 38 (06) : 917 - 923
  • [9] Disease-Modification in Epilepsy by Nonpharmacological Methods
    Jones, Nigel C.
    EPILEPSY CURRENTS, 2018, 18 (01) : 45 - 46
  • [10] Mixed results for disease-modification strategies for Alzheimer's disease
    Alisa Opar
    Nature Reviews Drug Discovery, 2008, 7 : 717 - 718
12345